Département Universitaire de Médecine Générale Faculté de Médecine de Marseille Aix-Marseille Université, Marseille, France.
Université Toulouse III-Paul Sabatier, Groupe de Recherche en Fertilité Humaine (Human Fertility Research Group), Toulouse, France.
PLoS One. 2018 May 29;13(5):e0195824. doi: 10.1371/journal.pone.0195824. eCollection 2018.
Since the 1970s, international research has actively pursued hormonal male contraception (HMC) and, to a lesser extent, thermal male contraception (TMC). Although the efficacy of TMC has been confirmed in limited populations, its acceptability has not been studied in either potential users or potential prescribers.
A cross-sectional descriptive multicentre study of potential male users of TMC (new fathers) and potential prescribers of TMC (new providers) was conducted between November 2016 and February 2017.The participants completed a 3-part survey, and their responses were evaluated to i) determine their socio-demographic profiles; ii) identify personal experiences with contraception; and iii) gauge the participants' knowledge, interest and preference for male contraception, particularly TMC. For new providers only, the survey included a fourth part to evaluate professional experience with male contraception.
The participation rate was 51% for new fathers (305 NFs) and 34% for new providers (300 NPs, including 97 men (male new providers, MNPs) and 203 women (female new providers, FNPs)). Only 3% of NFs and 15% of NPs knew about TMC (including 26% of the MNPs and 10% of the FNPs, p<0.01). After reading information on TMC, new fathers were significantly less willing to try TMC (29%) than were new providers (40%) (p<0.01). The 3 main advantages of TMC for the new fathers included the following factors: "natural" (52%), "without side effects" (38%) and "non-hormonal" (36%). The main disadvantages were "lengthy wear time" (56%), "daily undergarment wear" (43%) and "concern about possible discomfort" (39%).
Young male and female providers have limited knowledge of male contraception, are interested in further information and would generally prescribe TMC to their patients. Successful expansion of the use of male contraception, including TMC, would require distribution of better information to potential users and providers.
自 20 世纪 70 年代以来,国际研究一直在积极探索激素男性避孕法(HMC)和在较小程度上探索热男性避孕法(TMC)。尽管 TMC 的疗效已在有限的人群中得到证实,但无论是在潜在使用者还是潜在处方者中,都尚未对其可接受性进行研究。
2016 年 11 月至 2017 年 2 月期间,对 TMC 的潜在男性使用者(新父亲)和 TMC 的潜在处方者(新提供者)进行了一项横断面描述性多中心研究。参与者完成了三部分的调查,评估他们的回答,以:i)确定他们的社会人口统计学概况;ii)确定个人避孕经验;iii)评估参与者对男性避孕,特别是 TMC 的知识、兴趣和偏好。仅对新提供者进行了第四部分调查,以评估他们在男性避孕方面的专业经验。
新父亲的参与率为 51%(305 名 NF),新提供者的参与率为 34%(300 名 NP,包括 97 名男性(男性新提供者,MNP)和 203 名女性(女性新提供者,FNP))。只有 3%的 NF 和 15%的 NP 知道 TMC(包括 26%的 MNP 和 10%的 FNP,p<0.01)。阅读 TMC 信息后,新父亲尝试 TMC 的意愿明显低于新提供者(29%对 40%)(p<0.01)。新父亲认为 TMC 的 3 个主要优点包括以下因素:“自然”(52%)、“无副作用”(38%)和“非激素”(36%)。主要缺点是“佩戴时间长”(56%)、“每天穿内衣”(43%)和“担心可能不舒服”(39%)。
年轻的男性和女性提供者对男性避孕的知识有限,他们有兴趣了解更多信息,并普遍愿意为他们的患者开 TMC。要成功扩大男性避孕,包括 TMC 的使用,需要向潜在使用者和提供者更好地分发信息。